China Grand Enterprises

Activity by year

2017201820192020202120222023202420252026

Partnership

Nov 13, 2017PARTNERSHIPHong Kong, Hong Kong SAR China$15.0M
Grand Pharma and Donghai Capital to form joint venture for cardiovascular medical devices
Grand Pharmaceutical Group (00512) announced plans to form a joint venture in Hong Kong with Donghai Capital, a subsidiary of its controlling shareholder China Grand Enterprises. The JV, with a total investment of about $15 million, will focus on selling cardiovascular medical devices, including investing in North American manufacturers and establishing sales channels in China.
Grand Pharmaceutical Group partner Donghai Capital partner China Grand Enterprises investor #Medical Devices beta.zhitongcaijing.com

Loading…

China Grand Enterprises: plants, expansions, contracts and acquisitions · Endata